FDA
-
-
-
-
-
-
-
Verrica doses first U.S. patient in COVE-3 trial for common warts
-
-
-
-
-
-
-
Verrica Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 12, 2026
-
-
-
-
-
-
-
Verrica Pharmaceuticals Appoints Chris Chapman as Chief Commercial Officer
-
-
-
-
-
-
-
Verrica Pharmaceuticals Announces Private Placement Financing of $50 Million to Retire Debt and Extend Cash Runway
-
-
-
-
-
-
-
Verrica Pharmaceuticals to present VP-315 data at cancer meeting
-
-
-
-
-
-
-
Verrica Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 12, 2025
-
-
-
-
-
-
-
Verrica Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 13, 2025
-
328,148 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

